1. Wu, Hong, Liu, Yiqiang, Liu, Qianshi, Bian, Xiu-Wu, Xu, Chuan. 2024. HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing. In Science advances, 10, eadl6083. doi:10.1126/sciadv.adl6083. https://pubmed.ncbi.nlm.nih.gov/38838151/
2. Isakova, J T, Vinnikov, D, Kipen, V N, Shaimbetov, B O, Kudaibergenova, I O. 2020. Gene-to-gene interactions and the association of TP53, XRCC1, TNFα, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females. In Breast cancer (Tokyo, Japan), 27, 938-946. doi:10.1007/s12282-020-01092-1. https://pubmed.ncbi.nlm.nih.gov/32297247/
3. Ke, Hanni, Tang, Shuyan, Guo, Ting, Jin, Li, Chen, Zi-Jiang. 2023. Landscape of pathogenic mutations in premature ovarian insufficiency. In Nature medicine, 29, 483-492. doi:10.1038/s41591-022-02194-3. https://pubmed.ncbi.nlm.nih.gov/36732629/
4. Lu, Xiao-Qing, Zhang, Jia-Qian, Zhang, Sheng-Xiao, Gao, Chong, Zhang, Huan-Hu. 2021. Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis. In BMC cancer, 21, 697. doi:10.1186/s12885-021-08358-7. https://pubmed.ncbi.nlm.nih.gov/34126961/
5. Guo, Kaixuan, Liu, Cheng, Shi, Juanyi, Li, Kuiqing, Xu, Kewei. 2023. HMMR promotes prostate cancer proliferation and metastasis via AURKA/mTORC2/E2F1 positive feedback loop. In Cell death discovery, 9, 48. doi:10.1038/s41420-023-01341-0. https://pubmed.ncbi.nlm.nih.gov/36750558/